Jenburkt Pharmaceuticals Shareholding

Jenburkt Pharmaceuticals Ltd Shareholding Pattern

The Jenburkt Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Jenburkt Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Jenburkt Pharmaceuticals Ltd (NSE: , BSE: 524731) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Jenburkt Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Jenburkt Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Jenburkt Pharmaceuticals Ltd shareholding for Dec 2025 is:

• Promoters: 46.65%
• FII: 0%
• DII: 0.12%
• Public: 53.24%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Jenburkt Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Jenburkt Pharmaceuticals Ltd.

• Dec 2025: 46.65%
• Sept 2025: 46.66%
• Jun 2025: 46.67%
• Mar 2025: 46.68%
• Dec 2024: 46.69%

Promoter stake remains largely stable, showing consistent ownership structure.

Jenburkt Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Jenburkt Pharmaceuticals Ltd.

• Dec 2025: 0%
• Sept 2025: 0%
• Jun 2025: 0%
• Mar 2025: 0%
• Dec 2024: 0%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Jenburkt Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 0.12%
• Sept 2025: 0.12%
• Jun 2025: 0.12%
• Mar 2025: 0.12%
• Dec 2024: 0.12%

DII holdings remain stable, reflecting steady institutional participation.

Jenburkt Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 53.24%
• Sept 2025: 53.22%
• Jun 2025: 53.22%
• Mar 2025: 53.20%
• Dec 2024: 53.20%

Public participation in Jenburkt Pharmaceuticals Ltd has increased, indicating rising retail investor interest.

Jenburkt Pharmaceuticals Ltd Government Holding

Government holding in Jenburkt Pharmaceuticals Ltd currently stands at 0%.

Jenburkt Pharmaceuticals Ltd operates without significant government ownership.

Jenburkt Pharmaceuticals Ltd Shareholding Analysis Summary

The Jenburkt Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Jenburkt Pharmaceuticals Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Jenburkt Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.